Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beuzeboc

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Human Vaccines & Immunotherapeutics|June 8, 2022
An ethics of HPV vaccination: beyond principlismHenri-Corto Stoeklé, Sakina Sekkate, Jean-Marc Ayoubi, et al.
Presse Medicale (Paris, France : 1983)|December 28, 2007
[Chemotherapy for prostate cancer]Jacques Medioni, Dimitri Dionysopoulos, Eugéniu Banu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Testicular germ cell tumors: prognosis]Makram Miladi, Michaël Peyromaure, Julien Remi, et al.
Urology|January 31, 2004
Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institutionMichaël Peyromaure, Jerôme Slama, Philippe Beuzeboc, et al.
Bulletin Du Cancer|September 13, 2007
[New targeted therapies in hormone-refractory prostate cancer]Stéphane Oudard, Eugeniu Banu, Florian Scotte, et al.
Investigational New Drugs|December 15, 2010
Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapyYoulia M Kirova, Vincent Servois, Cyrus Chargari, et al.
European Urology|August 30, 2005
Trastuzumab (Herceptin) in metastatic transitional cell carcinoma of the urinary tract: report on six patientsMichaël Peyromaure, Florian Scotté, Delphine Amsellem-Ouazana, et al.
Bulletin Du Cancer|March 21, 2007
[Reflexion on innovation diffusion factors: the case of Herceptin]Catherine Buron, Marianne Doz, Anne Vincent Salomon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Leiomyosarcoma of the renal pelvis]Michaël Peyromaure, Kaili Mao, Eva Compérat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Bulletin of synthesis 2005. Recommendations for clinical practice. Management of non metastatic prostate cancer]Michel Soulie, Philippe Beuzeboc, Pierre Richaud, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Human Vaccines & Immunotherapeutics|June 8, 2022
An ethics of HPV vaccination: beyond principlismHenri-Corto Stoeklé, Sakina Sekkate, Jean-Marc Ayoubi, et al.
Presse Medicale (Paris, France : 1983)|December 28, 2007
[Chemotherapy for prostate cancer]Jacques Medioni, Dimitri Dionysopoulos, Eugéniu Banu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Testicular germ cell tumors: prognosis]Makram Miladi, Michaël Peyromaure, Julien Remi, et al.
Urology|January 31, 2004
Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institutionMichaël Peyromaure, Jerôme Slama, Philippe Beuzeboc, et al.
Bulletin Du Cancer|September 13, 2007
[New targeted therapies in hormone-refractory prostate cancer]Stéphane Oudard, Eugeniu Banu, Florian Scotte, et al.
Investigational New Drugs|December 15, 2010
Further developments for improving response and tolerance to irradiation for advanced renal cancer: concurrent (mTOR) inhibitor RAD001 and helical tomotherapyYoulia M Kirova, Vincent Servois, Cyrus Chargari, et al.
European Urology|August 30, 2005
Trastuzumab (Herceptin) in metastatic transitional cell carcinoma of the urinary tract: report on six patientsMichaël Peyromaure, Florian Scotté, Delphine Amsellem-Ouazana, et al.
Bulletin Du Cancer|March 21, 2007
[Reflexion on innovation diffusion factors: the case of Herceptin]Catherine Buron, Marianne Doz, Anne Vincent Salomon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Leiomyosarcoma of the renal pelvis]Michaël Peyromaure, Kaili Mao, Eva Compérat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Bulletin of synthesis 2005. Recommendations for clinical practice. Management of non metastatic prostate cancer]Michel Soulie, Philippe Beuzeboc, Pierre Richaud, et al.
Pageof 13